HIF-1α is overexpressed in solid tumors due to intratumoral hypoxia, genetic alterations, or both [12, 18, 22, 23], and thus may be a predominant regulator that contributes to elevated levels of PKM2 in human tumor tissues. The gene discussed is HIF1A; the disease is neoplasm.